NathanBrasharesSackettMDMS

Addiction

University of Washington, Resident Physician

Dr. Sackett is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1959 NE Pacific St
Seattle, WA 98195
Phone+1 206-520-5700

Fax+1 206-568-7043

PubMed

4 citations
Quality of Comprehensive HIV Care in Underserved Communities Does Clinical Training Lead to Improvement
Starley B. Shade, Nathan Sackett, Kevin Khamarko, Kimberly A. Koester, Jennifer Bie
American Journal of Medical Quality. 2013-03-01
Bis(4-acetoxy--ethyl---propyl-tryptammonium) fumarate-fumaric acid (1/1).
Duyen N K Pham, Nathan B Sackett, Andrew R Chadeayne, James A Golen, David R Manke
Iucrdata. 2023-09-01
Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.
Brian S Barnett, Anahita Bassir Nia, Nathan B Sackett, Jeremy Weleff
Frontiers in Psychiatry. 2023-01-01

Seattle’s Psychedelic Revolution Has ArrivedFebruary 22nd, 2022
Experts Say ‘Magic Mushrooms’ Can Be a Pathway to Treatment. Will WA Legislators Agree?February 7th, 2022
This Seattle Clinic Is Treating Some Patients with KetamineNovember 17th, 2021
Join now to see all